News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Adenovirus Small e1a Alters Global Patterns of Histone Modification
A research team from the University of California recently showed that adenovirus small early region 1a (e1a) protein interaction with p300 and CBP result in a threefold reduction of total cellular histone H3 lysine 18 acetylation (H3K18). CBP and p300 seem to be essential for the reaction at this position because a specific hypoacetylation occurs at H3K18 upon knockdown of their genes. The SV40 T antigen was also observed to trigger H3K18 hypoacetylation.
The binding of RB proteins and the histone acetyl transferases p300 and CBP by e1a drives cells into the S phase of the cell cycle. RB interaction removes e1a from its DNA-bound E2F transcription factors, resulting in the release of the cell cycle genes. The role of CBP and p300 may be clarified by the observation that global hypoacetylation at H3K18 occurs in prostate carcinomas with poor prognosis. Thus, the processes responsible for global H3K18 hypoacetylation could play a role oncogenic transformation.
Related antibodies on antibodies-online.com:
Histon H3, Lysin 18 acetylated
Antibodies for the research area cell cycle: »Show antibodies
Antibodies for the research area oncology: »Show antibodies
Antibodies for the research area virology: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

